New Delhi: The US Food and Drug Administration has approved the first at-home COVID-19 test kit, which is expected to bring coronavirus testing to the doorsteps of every household. The first at-home test kit has been developed by LabCorp, a US company which has a network of medical laboratories across the country. It costs USD 119 in the United States. Also Read - THIS City in India to Begin Door-to-door Vaccination Drive From Monday. All You Need to Know

How does it work? Also Read - India's Remotest Corners May Soon Seen Vaccine Delivery Through Drones, Bids Invited: Report

1. This is a test where under certain circumstances with doctor supervision, a test can be mailed to a patient. Also Read - Breaking News LIVE Updates: Congress Leader of Opposition in Uttarakhand Assembly, Indira Hridayesh, Dies

2. The patient can perform the self-swab.

3. The patient will have to mail it back and wait for the results.

4. All this will happen under the guidance of a licensed physician.

Earlier this week, Adam Schechter, president and CEO of LabCorp said that its at-home collection kits are designed to make it easier and safer to test healthcare workers and first responders during this important time.

The authorisation permits nasal swab specimens to be collected at home using the test home collection kit if recommended by a healthcare provider after completing a COVID-19 questionnaire, LabCorp said.

(With PTI Inputs)